Associations between hyperuricemia and ultrasound-detected knee synovial abnormalities in middle-aged and older population: a cross-sectional study

Qianlin Weng,Ting Jiang,Weiya Zhang,Michael Doherty,Zidan Yang,Jie Wei
DOI: https://doi.org/10.1186/s13018-024-04708-w
IF: 2.6
2024-04-04
Journal of Orthopaedic Surgery and Research
Abstract:Abstract Objectives Knee synovial abnormalities, potentially treatment targets for knee pain and osteoarthritis, are common in middle-aged and older population, but its etiology remains unclear. We examined the associations between hyperuricemia and knee synovial abnormalities detected by ultrasound in a general population sample. Methods Participants aged ≥ 50 years were from a community-based observational study. Hyperuricemia was defined as serum urate (SU) level > 416 μmol/L in men and > 357 μmol/L in women. Ultrasound of both knees was performed to determine the presence of synovial abnormalities, i.e., synovial hypertrophy, effusion, or Power Doppler signal (PDS). We examined the relation of hyperuricemia to prevalence of knee synovial abnormalities and its laterality, and the dose-response relationships between SU levels and the prevalence of knee synovial abnormalities. Results In total, 3,405 participants were included in the analysis. Hyperuricemia was associated with higher prevalence of knee synovial abnormality (adjusted odds ratio [aOR] = 1.21, 95% confidence interval [CI]: 1.02 to 1.43), synovial hypertrophy (aOR = 1.33, 95% CI: 1.05 to 1.68), and effusion (aOR = 1.21, 95% CI: 1.02 to 1.44), respectively. There were dose-response relationships between SU levels and synovial abnormalities. Additionally, the hyperuricemia was more associated with prevalence of bilateral than with that of unilateral knee synovial abnormality, synovial hypertrophy, or effusion; however, no significant association was observed between hyperuricemia and PDS. Conclusion In this population-based study we found that hyperuricemia was associated with higher prevalence of knee synovial abnormality, synovial hypertrophy and effusion, suggesting that hyperuricemia may play a role in pathogenesis of knee synovial abnormalities.
orthopedics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between hyperuricemia and knee joint synovial abnormalities. Specifically, the study aims to investigate whether hyperuricemia is related to the incidence of knee joint synovial abnormalities (such as synovial thickening, effusion or power Doppler signal) detected by ultrasound and its contralaterality in the general population, and to explore the dose - response relationship between serum uric acid levels and the incidence of knee joint synovial abnormalities. ### Research Background Knee joint synovial abnormalities are relatively common in middle - aged and elderly people, and their prevalence rates are 18.1% - 53.1% for synovial thickening, 46.6% - 69.7% for effusion, and 4.9% - 31.8% for power Doppler signal. Increasing evidence shows that synovial abnormalities are related to the occurrence and development of knee pain and osteoarthritis, which suggests potential targets for prevention and treatment. However, the etiology of knee joint synovial abnormalities is still unclear, resulting in limited intervention measures. ### Research Objectives 1. **Explore the relationship between hyperuricemia and knee joint synovial abnormalities**: Evaluate whether hyperuricemia is related to the incidence of knee joint synovial abnormalities. 2. **Analyze the dose - response relationship**: Explore the dose - response relationship between serum uric acid levels and the incidence of knee joint synovial abnormalities. 3. **Investigate contralaterality**: Analyze the relationship between hyperuricemia and the unilateral or bilateral distribution of knee joint synovial abnormalities. ### Methods - **Research design**: Cross - sectional study, based on the community - based cohort study in Longshan County, Hunan Province, China (Xiangya Osteoarthritis Study, XO Study). - **Participants**: Community residents aged ≥50 years. - **Definition of hyperuricemia**: Serum uric acid (SU) level > 416 µmol/L in men and > 357 µmol/L in women. - **Ultrasound examination**: Use ultrasound to examine the knee joint and evaluate synovial thickening, effusion and power Doppler signal. - **Statistical analysis**: Use the generalized estimating equation (GEE) and proportional - odds logistic regression model for analysis, adjusting for potential confounding factors. ### Results - **Relationship between hyperuricemia and knee joint synovial abnormalities**: Hyperuricemia is significantly associated with a higher incidence of knee joint synovial abnormalities (adjusted odds ratio [aOR] = 1.21, 95% CI: 1.02 to 1.43), especially synovial thickening (aOR = 1.33, 95% CI: 1.05 to 1.68) and effusion (aOR = 1.21, 95% CI: 1.02 to 1.44). - **Dose - response relationship**: There is a dose - response relationship between serum uric acid levels and the incidence of knee joint synovial abnormalities. - **Contralaterality**: Hyperuricemia is associated with a higher incidence of bilateral knee joint synovial abnormalities, but has no significant association with unilateral synovial abnormalities. ### Conclusion This population - based study found that hyperuricemia is associated with a higher incidence of knee joint synovial abnormalities, especially in terms of synovial thickening and effusion. These results suggest that hyperuricemia may play an important role in the pathogenesis of knee joint synovial abnormalities. Future studies need to further verify the causal relationship and explore whether reducing serum uric acid levels can improve knee joint synovial abnormalities.